This is the authors' abstract. We don't add key points for this paper.
A series of twenty-two new trifloromethyl benzimidazole derivatives were prepared based on azide and DCC coupling of 2-(2-(trifluoromethyl)-1H-benzoimidazol-1-yl) ethanoic acid derivatives with amino acids to give the amino acid esters; methyl 2-[(2-(2-(trifluoromethyl)-1H-benzimidazol-1-yl)acetamido] alkanoates. The amino acid esters reacted with hydrazine to produce the corresponding hydrazides that were finally condensed with p-fluorobenzaldehyde to obtain the hydrazones. The synthesized compounds were evaluated for their ability to bind to the crystal structure of E. coli (PDB = 1KZN) and the crystal structure of S. aureus (PDB = 1JIJ) bacteria, revealing good binding affinities. Notably, compounds 5e and 5k demonstrated primising interactive binding mode with the key amino acids like the co-crystallized ligands. As a result, they can be further tested as potent antimicrobial agents.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Rayes et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: